View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Offi...

OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer NANTES, France, August 20, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced the appointment of Thomas Gidoin as Chief Financial Officer. Thomas joins the Executive Committee, bringing over 15 years of deep international expertise in capital markets, financial strategy, and governance to the company. Thomas Gidoin is an experienced biopharma finance executive with a strong track record in strategic financial leadership, both in private and public companies. Prior to...

 PRESS RELEASE

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Finan...

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier NANTES, France - 20 août 2025, 18 h 00 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce aujourd’hui la nomination de Thomas Gidoin au poste de Directeur Financier. Thomas rejoint le Comité Exécutif, apportant à la Société plus de 15 ans d’une large expertise internationale dans les marchés financiers, la stratégie financière et la gouvernance. Thomas Gidoin est un dirigeant financier expérimenté dans le secteur biopharmaceutique, doté d’une solide expertise en stratégie d’entreprise et finan...

 PRESS RELEASE

PRESS RELEASE: CMB.TECH completes merger with Golden Ocean

PRESS RELEASE: CMB.TECH completes merger with Golden Ocean Antwerp, Aug. 20, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMB.TECH”) is pleased to announce that it has successfully completed the stock-for-stock merger between Golden Ocean Group Limited (“Golden Ocean”) and CMB.TECH Bermuda Ltd., a wholly-owned subsidiary of CMB.TECH, with CMB.TECH Bermuda Ltd. as the surviving company, and with CMB.TECH as the issuer of the merger consideration shares (the “Merger”).   Approval by Golden Ocean shareholders  At yesterday’s s...

Guy Sips ... (+7)
  • Guy Sips
  • Kristof Samoy
  • Livio Luyten
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi
 PRESS RELEASE

PRESS RELEASE: Golden Ocean SGM results

PRESS RELEASE: Golden Ocean SGM results Antwerp, Aug. 19, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) notes that Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean") has announced that it held a Special General Meeting ("Golden Ocean SGM") of the shareholders of Golden Ocean today, 19 August 2025, at 09:00 (local time) at Hamilton Princess and Beach Club, 76 Pitts Bay Road, Hamilton HM 08. Golden Ocean has announced that all resolutions set out in the notice of the Golden Ocean SGM were approved by the shareho...

 PRESS RELEASE

Virbac:: Paul Martingell's compensation terms

Virbac:: Paul Martingell's compensation terms The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting upon the recommendation of the appointments and compensation committee, has approved the compensation terms for Paul Martingell for the duration of his mandate, as detailed below. In accordance with applicable regulations, Paul Martingell's compensation elements will be submitted for the approval of the shareholders ("ex ante" and "ex post" votes). Fixed compensationThe board of directors has set Paul Martin...

 PRESS RELEASE

VIRBAC: Informations sur les conditions de rémunération de Paul Martin...

VIRBAC: Informations sur les conditions de rémunération de Paul Martingell Le conseil d’administration de Virbac précise les conditions de rémunération de Paul Matingell en qualité de directeur général. Le conseil d’administration a arrêté, sur recommandation du comité des nominations et des rémunérations, les conditions de rémunération de Paul Martingell pour la durée de son mandat, telles que précisées ci-après. Conformément aux règles applicables, les éléments de rémunération de Paul Martingell seront soumis au vote des actionnaires (vote "ex ante" et vote "ex post"). Rémunération fixe...

 PRESS RELEASE

Press release: Publication of exemption document

Press release: Publication of exemption document Antwerp, Aug. 14, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) hereby informs that it has published an exemption document and a special report of the supervisory board, in connection with the contemplated stock-for-stock merger with Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean" and the “Merger”). Exemption Document In accordance with Article 1 (5) (f) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (the “Prospect...

Hilde Van Boxstael ... (+8)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Lewi

Morning Notes : ADYEN NA, CMBT BB, FUR NA, NEXTA BB, SIP BB, SHUR BB, ...

: ADYEN NA, CMBT BB, FUR NA, NEXTA BB, SIP BB, SHUR BB, FAST NA, ZEAL DC

 PRESS RELEASE

CMB.TECH Business update Q2 2025 results

CMB.TECH Business update Q2 2025 results Antwerp, Aug. 14, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its second quarter 2025 earnings prior to market opening on Thursday 28 August 2025 and will host a conference call at 8 a.m. EST / 2 p.m. CET to discuss the results for the quarter. Due to the proximity of the expected closing date of the contemplated stock-for-stock merger between CMB.TECH and Golden Ocean Group Limited (“Golden Ocean”), CMB.TECH already provides preliminary figures related to the Q2 2025 results...

Ebro Foods S.A: 1 director

A director at Ebro Foods S.A bought 7,000 shares at 17.205EUR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Informations relatives au nombre total de droits de vote et d’actions ...

Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 12 août 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), société intégrée de biotechnologie qui développe des immunothérapies innovantes, en direct ou via des partenariats, pour l’activation et la régulation immunitaire en immuno-oncologie et dans les maladies auto-immu...

 PRESS RELEASE

CMB.TECH's update on the Golden Ocean merger process

CMB.TECH's update on the Golden Ocean merger process Antwerp, Aug. 11, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) provides an additional market update on the progress of the contemplated stock-for-stock merger between CMB.TECH and Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean"). The transaction is structured as a stock-for-stock merger, with Golden Ocean merging with and into CMB.TECH Bermuda Ltd. ("CMB.TECH Bermuda”), a wholly-owned subsidiary of CMB.TECH, with CMB.TECH Bermuda as the surviving company ...

Tijs Hollestelle
  • Tijs Hollestelle

BAM/Time to take its valuation out of second division/BUY

We maintain our BUY rating and raise our target price from €5.90 to €9.00 per share. We increase our FY25F and FY26F EPS estimates by 13% and 9% respectively following better-than-expected 1H25 results and a slightly higher FY25 adjusted EBITDA margin outlook. We use a new 10.5x target PER to back our new €9.00 target price and move to our FY26F EPS. Previously we valued BAM using the stock's long-term historical mid-cycle multiple of 8.5x and now take the high end of the multiple trading range ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 07/30/2025

Nexans: Strong set of results and resignation of its CFO|OPmobility prices its new 2031 bonds|Altarea: recovery momentum in housing firmed up in H1 2025|Worldline: confirmation of major operating challenges in H1 2025|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 30/07/2025

Nexans: Strong set of results and resignation of its CFO|OPmobility price ses nouvelles obligations 2031|Altarea : la dynamique de reprise sur le logement se confirme au S1 2025|Worldline : confirmation d’importantes difficultés au S1 2025|

Juan Ros-Padilla
  • Juan Ros-Padilla
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch